Topics

Clinical Catch-Up: October 21-25

20:00 EDT 27 Oct 2019 | BioSpace

Although the clinical trial news last week was dominated by the stunning reversal of Biogen and Eisai’s clinical trials of aducanumab for Alzheimer’s disease, there was plenty of other trial news. Here’s a look.

Original Article: Clinical Catch-Up: October 21-25

NEXT ARTICLE

More From BioPortfolio on "Clinical Catch-Up: October 21-25"

Quick Search

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...